MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness 
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development 
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing 
Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
Dublin, Dec. 07, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/8bqskf/transdermal_drug) has announced the addition of Jain PharmaBiotech's new report "Transdermal Drug Delivery - Technologies, Markets, and Companies" to their offering.
The market for transdermal drug delivery is analyzed according to technologies and therapeutic areas from 2014 to 2024
This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes. Various transdermal drug delivery technologies are described including the use of suitable formulations, carriers and penetration enhancers.
The most commonly used transdermal system is the skin patch using various types of technologies. Nanoparticles as well as the use of physical agents to facilitate transcutaneous drug delivery is described. Microneedle and needleless technologies are also described.
Transdermal technologies may be applied for several categories of pharmaceuticals used for the treatment of disorders of the skin or for systemic effect to treat diseases of other organs. Several transdermal products and applications include hormone replacement therapy, contraception, management of pain, angina pectoris, smoking cessation and neurological disorders such as Parkinson's disease.
Benefits of this report:
- Up-to-date one-stop information on transdermal drug delivery
- Description of 109 companies involved and 110 collaborations in this area
- Market analysis 2014-2024
- Market values in major regions
- Strategies for developing markets for transdermal drug delivery
- A selected bibliography of 220 publications
- Text is supplemented by 22 tables and 13 figures
Key Topics Covered:
Executive Summary
1. Basics of Transdermal Drug Delivery
2. Transdermal Drug Delivery Technologies
3. Transdermal Therapeutics
4. Markets for Transdermal Drug Delivery
5. Companies involved in transdermal drug delivery
6. References
For more information visit http://www.researchandmarkets.com/research/8bqskf/transdermal_drug
Source: Jain PharmaBiotech
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Transdermal and Transmucosal Drug Delivery
